Lixisenatide clinical experience on patients with type 2 diabetes and obesity in endocrinology offices in Malaga

Endocrinol Nutr. 2015 Dec;62(10):512-4. doi: 10.1016/j.endonu.2015.07.004. Epub 2015 Sep 28.
[Article in English, Spanish]
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anthropometry
  • Blood Glucose / analysis
  • Blood Pressure / drug effects
  • Body Weight / drug effects
  • Cholesterol / blood
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Lipids / blood
  • Male
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / drug therapy
  • Middle Aged
  • Obesity / complications*
  • Peptides / pharmacology
  • Peptides / therapeutic use*
  • Prospective Studies
  • Spain

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Lipids
  • Peptides
  • lixisenatide
  • Cholesterol